Insulin lispro Subcutaneous and Olaratumab Intravenous
Determining the interaction of Insulin lispro Subcutaneous and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Oleptro
- Insulin lispro Subcutaneous-Oleptro Oral
- Insulin lispro Subcutaneous-Olmesartan
- Insulin lispro Subcutaneous-Olmesartan and Hydrochlorothiazide
- Insulin lispro Subcutaneous-Olmesartan Medoxomil
- Insulin lispro Subcutaneous-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Insulin NPH
- Olaratumab Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Olaratumab Intravenous-Insulin NPH (Vials)
- Olaratumab Intravenous-Insulin NPH and Insulin Regular
- Olaratumab Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Olaratumab Intravenous-Insulin NPH and Insulin Regular (Vials)